Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies
暂无分享,去创建一个
David C. Krakauer | Anthony S. Fauci | Mario A. Ostrowski | G. Learn | D. Krakauer | M. Ostrowski | A. Fauci | L. Ehler | Sharilyn K. Stanley | Shawn J. Justement | Linda A. Ehler | Yuexia Li | Gerald Learn | Martin Nowak | S. Justement | S. Stanley | M. Nowak | Yuexia Li
[1] E. G. Shpaer,et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.
[2] P. Simmonds,et al. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.
[3] C. Broder,et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.
[4] K. Peden,et al. STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1 , 1997, The Journal of experimental medicine.
[5] P. Pileri,et al. Antigen-independent activation of naive and memory resting T cells by a cytokine combination , 1994, The Journal of experimental medicine.
[6] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[7] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[8] C. Kuiken,et al. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population , 1995, Journal of virology.
[9] S. Swindells,et al. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. , 1996, The Journal of infectious diseases.
[10] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[11] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[12] M. Ostrowski,et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. , 1998, Journal of immunology.
[13] Marc Parmentier,et al. A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.
[14] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[15] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Albert,et al. REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION , 1986, The Lancet.
[18] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[19] M. Ascher,et al. AIDS as immune system activation. II. The panergic imnesia hypothesis. , 1990, Journal of acquired immune deficiency syndromes.
[20] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[21] W. Allan,et al. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia , 1993, The Journal of experimental medicine.
[22] Martin A. Nowak,et al. Causes of HIV diversity , 1995, Nature.
[23] Z. Grossman,et al. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Harada,et al. Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.
[25] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[26] D. Weissman,et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. , 1996, Journal of immunology.
[27] W. O'brien,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.
[28] É. Oksenhendler,et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes , 1994, Cell.
[29] E. Holmes,et al. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop , 1994, Journal of virology.
[30] H. Bremermann,et al. Aids as Immune System Activation , 1995 .
[31] M. Kimura. The Neutral Theory of Molecular Evolution: Introduction , 1983 .
[32] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[33] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[34] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[35] Lawrence Corey,et al. Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.
[36] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[37] B. Chesebro,et al. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.
[38] J. Adachi,et al. MOLPHY version 2.3 : programs for molecular phylogenetics based on maximum likelihood , 1996 .
[39] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[40] D. Ho. HIV-1 viraemia and influenza , 1992, The Lancet.
[41] C. Broder,et al. CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.
[42] P. Kvale,et al. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[43] H. Schuitemaker,et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.
[44] N. Letvin,et al. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination , 1998, Nature Medicine.
[45] Characterization,et al. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.
[46] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[47] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[48] M. Nei,et al. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.
[49] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[50] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[51] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[52] HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. , 1991, Disease markers.
[53] R. Doms,et al. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. , 1997, Virology.
[54] A. Rodrigo,et al. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. , 1995, PCR methods and applications.
[55] T. Jukes,et al. The neutral theory of molecular evolution. , 2000, Genetics.
[56] C H Fox,et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.